{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:16:45Z","timestamp":1790335005037,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA17104"],"award-info":[{"award-number":["CA17104"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107232","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T11:32:30Z","timestamp":1606735950000},"page":"107232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2"],"prefix":"10.1016","volume":"90","author":[{"given":"Arif","family":"Kivrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berdan","family":"Ula\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Kivrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107232_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"International Journal of Surgery"},{"issue":"5","key":"10.1016\/j.intimp.2020.107232_b0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.intimp.2020.107232_b0015","first-page":"1","article-title":"Kidney involvement in COVID-19 and rationale for extracorporeal therapies","author":"Ronco","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2020.107232_b0020","article-title":"Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019","author":"Liu","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.intimp.2020.107232_b0025","doi-asserted-by":"crossref","unstructured":"Rotondi V, Andriano L, Dowd JB, Mills MC. Early evidence that social distancing and public health interventions flatten the COVID-19 curve in Italy. 2020.","DOI":"10.31219\/osf.io\/wah4e"},{"key":"10.1016\/j.intimp.2020.107232_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2020.03.179","article-title":"Effects of the COVID-19 Outbreak in Northern Italy: Perspectives from the Bergamo Neurosurgery Department","volume":"137","author":"Bernucci","year":"2020","journal-title":"World Neurosurgery"},{"key":"10.1016\/j.intimp.2020.107232_b0035","unstructured":"Italian GovernmentPresidency of the Council of Ministers. Coronavirus, le misure adottate dal Governo. 2020."},{"key":"10.1016\/j.intimp.2020.107232_b0040","unstructured":"Italian Society of Infectious and Tropical Diseases, Handbook for the care of people with disease-COVI 19, Edition 2.0, March 13, 2020, https:\/\/www.simit.org\/news\/11-vademecum-per-la-cura-delle-persone-con-malattia-da-covid-19."},{"issue":"8","key":"10.1016\/j.intimp.2020.107232_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237960","article-title":"Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona","volume":"15","author":"Sis\u00f3-Almirall","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.107232_b0050","unstructured":"Ministerio de Sanidad, Comparecencia Sobre Las Actuaciones Desarrolladas En Relaci\u00f3n Con El Coronavirus (COVID-19), 2020, https:\/\/www.mscbs.gob.es\/gabinete\/notasPrensa.do?metodo=detalle&id=4825."},{"key":"10.1016\/j.intimp.2020.107232_b0055","unstructured":"Spanish Agency for Medicines and Health Products, Tratamientos disponibles sujetos a condiciones especiales de acceso para el manejo de la infecci\u00f3n respiratoria por SARS-CoV-2, 2020, https:\/\/www.aemps.gob.es\/la-aemps\/ultima-informacion-de-la-aemps-acerca-del-covid%E2%80%9119\/tratamientos-disponibles-para-el-manejo-de-la-infeccion-respiratoria-por-sars-cov-2\/?lang=en."},{"key":"10.1016\/j.intimp.2020.107232_b0060","unstructured":"U.S. National Institutes of Health, Characteristics of Potential Antiviral Agents Under Evaluation for Treatment of COVID-19, 2020, https:\/\/www.covid19treatmentguidelines.nih.gov\/tables\/table-2b\/."},{"issue":"4","key":"10.1016\/j.intimp.2020.107232_b0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pulmoe.2020.04.008","article-title":"COVID-19 in Brazil","volume":"26","author":"Marson","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.intimp.2020.107232_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101613","article-title":"COVID-19 in Latin America: The implications of the first confirmed case in Brazil","volume":"35","author":"Rodriguez-Morales","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.107232_b0075","doi-asserted-by":"crossref","unstructured":"Croda JHR, Garcia LP. Resposta imediata da Vigil\u00e2ncia em Sa\u00fade \u00e0 epidemia da COVID-19. SciELO Public Health; 2020.","DOI":"10.5123\/S1679-49742020000100021"},{"key":"10.1016\/j.intimp.2020.107232_b0080","doi-asserted-by":"crossref","unstructured":"Garcia LP, Duarte E. Interven\u00e7\u00f5es n\u00e3o farmacol\u00f3gicas para o enfrentamento \u00e0 epidemia da COVID-19 no Brasil. SciELO Public Health; 2020.","DOI":"10.5123\/S1679-49742020000200009"},{"key":"10.1016\/j.intimp.2020.107232_b0085","unstructured":"Minist\u00e9rio Da Sa\u00fade, Orienta\u00e7\u00f5es Do Minist\u00e9rio Da Sa\u00fade Para Manuseio Medicamentoso Precoce De Pacientes Com Diagn\u00f3stico Da COVID-19, 2020, https:\/\/saude.gov.br\/images\/pdf\/2020\/August\/12\/COVID-11ago2020-17h16.pdf."},{"key":"10.1016\/j.intimp.2020.107232_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30314-5","article-title":"Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series","author":"B\u00f6hmer","year":"2020","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.intimp.2020.107232_b0095","article-title":"Covid-19: Why Germany\u2019s case fatality rate seems so low","volume":"369","author":"Stafford","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2020.107232_b0100","article-title":"St\u00e4ndiger Arbeitskreis der Kompetenz- und Behandlungszentren f\u00fcr Krankheiten durch hochpathogene Erreger, Hinweise zu Erkennung","author":"Koch-Institut","year":"2020","journal-title":"Diagnostik und Therapie von Patienten mit COVID-19"},{"key":"10.1016\/j.intimp.2020.107232_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.031","article-title":"Transmission potential and severity of COVID-19 in South Korea","author":"Shim","year":"2020","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/j.intimp.2020.107232_b0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijid.2020.03.031","article-title":"Transmission potential and severity of COVID-19 in South Korea","volume":"93","author":"Shim","year":"2020","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/j.intimp.2020.107232_b0115","unstructured":"Kim C. As Covid-19 cases rise, South Korea raises virus threat level to its maximum. Vox Vox2020 2020."},{"issue":"3","key":"10.1016\/j.intimp.2020.107232_b0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.intimp.2020.107232_b0125","unstructured":"Republic of Korea, Ministry of Food and Drug Safety, Korea Centers for Disease Control and Prevention, Special import approved for COVID-19 treatment, 2020, https:\/\/www.mfds.go.kr\/eng\/brd\/m_64\/view.do?seq=30&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1."},{"key":"10.1016\/j.intimp.2020.107232_b0130","doi-asserted-by":"crossref","unstructured":"Reshetnikov V, Mitrokhin O, Shepetovskaya N, Belova E, Jakovljevic M. Organizational measures aiming to combat COVID-19 in the Russian Federation: the first experience. Expert Review of Pharmacoeconomics & Outcomes Research 2020:null-null.","DOI":"10.1080\/14737167.2020.1823221"},{"key":"10.1016\/j.intimp.2020.107232_b0135","article-title":"COVID-19: Guidance for Employers in Russia","author":"Anna Shashina","year":"2020","journal-title":"Bird & Bird"},{"key":"10.1016\/j.intimp.2020.107232_b0140","first-page":"1","article-title":"Responses to the COVID-19 crisis in Russia, Ukraine, and Belarus","author":"\u00c5slund","year":"2020","journal-title":"Eurasian Geogr. Econ."},{"key":"10.1016\/j.intimp.2020.107232_b0145","unstructured":"Krasilnikov S. Coronavirus in Russia: The Latest News. The Moscow Times2020."},{"key":"10.1016\/j.intimp.2020.107232_b0150","unstructured":"Ministry of Health of Russia, Bpe\u043ce\u043d\u043d\u044be Me\u0442o\u0434\u0438\u0447ec\u043a\u0438e Pe\u043ao\u043ce\u043d\u0434a\u0446\u0438\u0438, 2020, https:\/\/static-0.rosminzdrav.ru\/system\/attachments\/attaches\/000\/050\/033\/original\/RESP_REC_V2.pdf."},{"key":"10.1016\/j.intimp.2020.107232_b0155","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc, COVID-19 (SARS-CoV-2 Enfeksiyonu) Eri\u015fkin Hasta Tedavisi, 2020, https:\/\/covid19.saglik.gov.tr\/Eklenti\/38355\/0\/covid-19rehberieriskinhastatedavisipdf.pdf."},{"key":"10.1016\/j.intimp.2020.107232_b0160","unstructured":"Chinese National Health Commission, Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition). 2020."},{"issue":"6872","key":"10.1016\/j.intimp.2020.107232_b0165","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2020.107232_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.intimp.2020.107232_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel","volume":"304","author":"Thompson","year":"2010","journal-title":"Jama-Journal of the American Medical Association"},{"issue":"20","key":"10.1016\/j.intimp.2020.107232_b0180","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection","volume":"358","author":"Riddler","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.intimp.2020.107232_b0185","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.107232_b0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5694\/mja2.50673","article-title":"Clinical trials for the prevention and treatment ofCOVID-19: current state of play","volume":"213","author":"Davis","year":"2020","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.intimp.2020.107232_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111639","article-title":"An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment","volume":"144","author":"Javorac","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2020.107232_b0200","unstructured":"Jensen MP, George M, Gilroy D, Sofat R. Beyond dexamethasone, emerging immuno-thrombotic therapies for COVID-19. British Journal of Clinical Pharmacology."},{"issue":"3","key":"10.1016\/j.intimp.2020.107232_b0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1440-1754.2000.00493.x","article-title":"Postnatal corticosteroids and sensorineural outcome at 5 years of age","volume":"36","author":"Doyle","year":"2000","journal-title":"J. Paediatr. Child Health"},{"issue":"9","key":"10.1016\/j.intimp.2020.107232_b0210","article-title":"Overview of the Pathogenesis and Treatment of SARS-CoV-2 for Clinicians","volume":"12","author":"Voto","year":"2020","journal-title":"A Comprehensive Literature Review. Cureus"},{"key":"10.1016\/j.intimp.2020.107232_b0215","doi-asserted-by":"crossref","unstructured":"Ajeet, Aggarwal B, Verma SK. Favipiravir May Acts as COVID-19 Main Protease PDB ID 6LU7 Inhibitor: Docking Analysis. Biointerface Research in Applied Chemistry 2020; 10 (6):6821-6828.","DOI":"10.33263\/BRIAC106.68216828"},{"issue":"12","key":"10.1016\/j.intimp.2020.107232_b0220","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1166\/jnn.2020.18955","article-title":"Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking","volume":"20","author":"Arouche","year":"2020","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.intimp.2020.107232_b0225","unstructured":"Dauby N, Van Praet S, Vanhomwegen C, Veliziotis I, Konopnicki D, Roman A. Tolerability of favipiravir therapy in critically ill patients with COVID-19: A report of four cases. Journal of Medical Virology."},{"key":"10.1016\/j.intimp.2020.107232_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173328","article-title":"Current pharmacological treatments for SARS-COV-2: A narrative review","author":"Nittari","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107232_b0235","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.drudis.2020.08.002","article-title":"Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites","volume":"25","author":"El Kantar","year":"2020","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.intimp.2020.107232_b0240","article-title":"Progress in the Research and Development of Anti-COVID-19 Drugs. Frontiers","author":"Huang","year":"2020","journal-title":"Public Health"},{"issue":"5","key":"10.1016\/j.intimp.2020.107232_b0245","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41423-020-0385-z","article-title":"Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107232_b0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.intimp.2020.107232_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","author":"Warren","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2020.107232_b0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"45","key":"10.1016\/j.intimp.2020.107232_b0265","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.intimp.2020.107232_b0270","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jtbi.2008.07.030","article-title":"Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL(pro) inhibitors","volume":"254","author":"Nukoolkarn","year":"2008","journal-title":"J. Theor. Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:30:54Z","timestamp":1744950654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"alternative-id":["S1567576920336997"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107232","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107232"}}